A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

April 30, 2000

Study Completion Date

April 30, 2000

Conditions
Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy
Interventions
DRUG

BRL 49653C

BRL 49653C 2 mg bid or placebo bid through weeks 1 to 24.

DRUG

Placebo

Trial Locations (1)

10002

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT01706211 - A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes | Biotech Hunter | Biotech Hunter